Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study

被引：0
|
作者：
Emma Houchen
Emil Loefroth
Raymond Schlienger
Clare Proudfoot
Stefano Corda
Sibasish Saha
Sarvesh K. Satwase
Rachel Studer
机构：
[1] Novartis Ireland Ltd.,
[2] Novartis Sweden AB,undefined
[3] Novartis Pharma AG,undefined
[4] Novartis Healthcare Pvt. Ltd,undefined
[5] Medical and Knowledge Solutions,undefined
[6] Novartis Global Service Center,undefined
来源：
Cardiology and Therapy | 2022年 / 11卷
关键词：
Angiotensin-converting enzyme inhibitor; Angiotensin receptor blocker; Angiotensin receptor neprilysin inhibitor; Heart failure; Sacubitril/valsartan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：113 / 127
页数：14
相关论文
共 50 条
  • [1] Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
    Houchen, Emma
    Loefroth, Emil
    Schlienger, Raymond
    Proudfoot, Clare
    Corda, Stefano
    Saha, Sibasish
    Satwase, Sarvesh K.
    Studer, Rachel
    CARDIOLOGY AND THERAPY, 2022, 11 (01) : 113 - 127
  • [2] Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Jena, Barada Prasad
    Suminska, Sylwia
    Eid, Carlos
    Khairnar, Rahul
    Farries, Gabriella
    Senni, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (05) : 1172 - 1174
  • [3] The impact of discontinuation of sacubitril-valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
    Amin, Osama A.
    Alaarag, Ahmed F.
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2021, 25 (03): : 163 - 169
  • [4] Cost-Effectiveness of Sacubitril-Valsartan Compared to Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction
    Febrinasari, Ratih P.
    Putra, Stefanus E.
    Hafizhan, Muhammad
    Probandari, Ari N.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 915 - 924
  • [5] Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis
    Ishii, Tsuyoshi
    Matsue, Yuya
    Matsunaga, Yuki
    Iekushi, Kazuma
    Homma, Yuji
    Morita, Yohei
    HEART AND VESSELS, 2024, 39 (01) : 25 - 34
  • [6] Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis
    Tsuyoshi Ishii
    Yuya Matsue
    Yuki Matsunaga
    Kazuma Iekushi
    Yuji Homma
    Yohei Morita
    Heart and Vessels, 2024, 39 : 25 - 34
  • [7] Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
    Gilstrap, Lauren G.
    Fonarow, Gregg C.
    Desai, Akshay S.
    Liang, Li
    Matsouaka, Roland
    DeVore, Adam D.
    Smith, Eric E.
    Heidenreich, Paul
    Hernandez, Adrian F.
    Yancy, Clyde W.
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (02):
  • [8] Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection fraction
    Jang, S. Y.
    Park, H. K.
    Park, B. E.
    Jung, M. S.
    Yang, D. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 61 - 61
  • [9] Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril-Valsartan for the Treatment of Heart Failure
    Sohani, Zahra N. N.
    Behlouli, Hassan
    de Moura, Cristiano Soares
    Abrahamowicz, Michal
    Pilote, Louise
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [10] Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction
    Park, Dae Yong
    An, Seokyung
    Attanasio, Steve
    Jolly, Neeraj
    Malhotra, Saurabh
    Doukky, Rami
    Samsky, Marc D.
    Sen, Sounok
    Ahmad, Tariq
    Nanna, Michael G.
    Vij, Aviral
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 187 : 84 - 92
12345